Why Most Universities Negotiate License Royalty Stacking Clauses Into Oblivion
A. KovacsRoyalty stacking clauses are one of those provisions that feel reasonable on paper and cause serious damage in practice. The logic sounds fair: if a licensee must pay royalties to multiple rights holders to commercialize a product, they shouldn't be crushed by the cumulative burden. So the license agreement lets them reduce what they owe your university if they're also paying others.
Clean in theory. Catastrophic in execution, when the clause is written badly.
Here's what happens in practice. A biotech company licenses a university's compound. The license includes a royalty stacking provision allowing the company to reduce the university's royalty rate by 50% of any third-party royalty payments, down to a floor of 1%. Two years later, the company licenses in a delivery technology, a manufacturing process patent, and a formulation patent from three other institutions. Total third-party royalties: 6%. The university's rate, originally 4%, gets cut to 1%. The university just watched three quarters of its royalty income disappear because it wrote a clause without thinking carefully about who controlled what.
The university negotiated against a hypothetical problem and gave away real money.
The Two Legitimate Concerns Getting Conflated
Royalty stacking protection addresses a real issue. Complex products, especially in pharma and medtech, routinely require licenses from multiple patent holders. If cumulative royalties hit 20-30%, the product economics collapse and nobody wins. Universities have a genuine interest in deals that actually close and companies that actually commercialize.
But most royalty stacking clauses don't distinguish between two very different situations: royalties on foundational IP that was required to make the product viable at all, and royalties on improvements or optimizations the company chose to license in later. Treating those the same way punishes the originating institution for decisions made entirely by the licensee after the deal closed.
There's also a verification problem nobody talks about. When a licensee claims royalty stacking offsets, who audits that? Most agreements have audit rights for royalty calculations, but the stacking offset calculation often lives in a different bucket. Companies can (and do) make allocation decisions that maximize their offset claims. Universities rarely push back because they don't have systems to track it.
What Tighter Drafting Actually Looks Like
A royalty stacking provision that protects both parties should define which categories of third-party IP are eligible for the offset. Patents that were essential to the core invention and were licensed before the deal closed deserve different treatment than patents the company acquired later for manufacturing convenience.
Caps matter too. Rather than an open-ended percentage reduction, specify a maximum total royalty burden (say, 15% of net sales) above which stacking kicks in, and tie the university's reduction to a proportional share of the excess burden rather than a blanket credit. If four licensors all contributed equally and the burden exceeds the cap, each takes a proportional haircut. Your institution doesn't subsidize the others.
The floor provision needs serious attention. A floor of 1% sounds like protection. For a blockbuster product, 1% is real money. For most university licenses, a 1% floor on $2 million in annual sales is barely worth the paperwork. Consider setting floors as dollar minimums rather than rate minimums, or including minimum annual payments that hold regardless of stacking calculations.
graph TD
A[Third-Party Royalty Claimed] --> B{Was IP Essential at Deal Close?}
B -- Yes --> C(Apply Proportional Offset)
B -- No --> D[No Offset Applies]
C --> E{Total Burden Exceeds Cap?}
E -- Yes --> F(Proportional Haircut Across All Licensors)
E -- No --> G[University Rate Unchanged]
The Negotiation Dynamic Nobody Prepares For
Most university tech transfer offices encounter royalty stacking discussions late in term sheet negotiations, when both sides are tired and eager to close. The company's counsel presents it as standard. The TTO attorney, under pressure to get the deal done, accepts language that wasn't scrutinized carefully enough.
Starting from a well-drafted internal template changes that dynamic. When your office walks in with specific, reasoned language already in place, you're not reacting to their standard clause. You're proposing a version that has internal logic they have to work to undo. That's a different negotiation.
Royalty stacking clauses aren't the sexiest part of a license agreement. They rarely come up in deal announcements or annual reports. But five years after signing, when a product is on the market and your royalty checks are half what your projections assumed, you'll wish someone had spent two more hours on the clause before the ink dried.
Get Commercializing Science in your inbox
New posts delivered directly. No spam.
No spam. Unsubscribe anytime.
Photo by